European pharmaceutical monopoly GlaxoSmithKline, with two European governments reached an agreement on drug prices announced. Agreement according to the company's price of some new drugs, immediately after release to the market by reviewing increase.
The company's pharmaceutical market, this method brings a new approach to pricing that was expected.
GlaxoSmithKline one of the countries with the signing of these agreements in France said.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment